Nikol S - Search Results

1

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.

Pastori D, Eikelboom JW, Anand SS, Patel MR, Tanguay JF, Ricco JB, Debus ES, Mazzolai L, Bauersachs R, Verhamme P, Bosch J, Nikol S, Nehler M, Aboyans V, Violi F. Pastori D, et al. Among authors: nikol s. Thromb Haemost. 2019 Apr;119(4):576-585. doi: 10.1055/s-0039-1678527. Epub 2019 Jan 31. Thromb Haemost. 2019. PMID: 30703812 Review.

2

Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.

Weissler EH, Jones WS, Desormais I, Debus S, Mazzolai L, Espinola-Klein C, Nikol S, Nehler M, Sillesen H, Aboyans V, Patel MR. Weissler EH, et al. Among authors: nikol s. Atherosclerosis. 2020 Dec;315:10-17. doi: 10.1016/j.atherosclerosis.2020.11.001. Epub 2020 Nov 6. Atherosclerosis. 2020. PMID: 33190107 Review.

3

The Role for Combined Antithrombotic Therapy With Platelet and Coagulation Inhibition After Lower Extremity Revascularization.

Weissler EH, Aboyans V, Bauersachs R, Brodmann M, Nikol S, Debus S, Patel MR, Jones WS. Weissler EH, et al. Among authors: nikol s. JACC Cardiovasc Interv. 2021 Apr 12;14(7):796-802. doi: 10.1016/j.jcin.2021.01.035. JACC Cardiovasc Interv. 2021. PMID: 33826501 Free PMC article. Review.

4

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial.

Norgren L, Weiss N, Nikol S, Hinchliffe RJ, Lantis JC, Patel MR, Reinecke H, Ofir R, Rosen Y, Peres D, Aberman Z. Norgren L, et al. Among authors: nikol s. Eur J Vasc Endovasc Surg. 2019 Apr;57(4):538-545. doi: 10.1016/j.ejvs.2018.11.008. Epub 2019 Jan 25. Eur J Vasc Endovasc Surg. 2019. PMID: 30686676 Free article.

5

Gene therapy in vascular disease.

Sedighiani F, Nikol S. Sedighiani F, et al. Among authors: nikol s. Surgeon. 2011 Dec;9(6):326-35. doi: 10.1016/j.surge.2011.05.003. Epub 2011 Jul 5. Surgeon. 2011. PMID: 22041646 Review.

6

Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update).

Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, Katsanos K, Mills JL, Nikol S, Reekers J, Venermo M, Zierler RE, Schaper NC; International Working Group on the Diabetic Foot (IWGDF). Hinchliffe RJ, et al. Among authors: nikol s. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3276. doi: 10.1002/dmrr.3276. Epub 2020 Jan 20. Diabetes Metab Res Rev. 2020. PMID: 31958217

7

Clinical experience with dual pathway inhibition therapy: case series and mini review.

Geisler T, Branch K, Nikol S. Geisler T, et al. Among authors: nikol s. Eur Heart J Case Rep. 2022 May 19;6(7):ytac201. doi: 10.1093/ehjcr/ytac201. eCollection 2022 Jul. Eur Heart J Case Rep. 2022. PMID: 35854882 Free PMC article.

8

Therapeutic angiogenesis for peripheral artery disease: cytokine therapy.

Kuhlmann MT, Klocke R, Nikol S. Kuhlmann MT, et al. Among authors: nikol s. Vasa. 2007 Nov;36(4):253-60. doi: 10.1024/0301-1526.36.4.253. Vasa. 2007. PMID: 18357917 Review.

9

Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease.

Niebuhr A, Henry T, Goldman J, Baumgartner I, van Belle E, Gerss J, Hirsch AT, Nikol S. Niebuhr A, et al. Among authors: nikol s. Gene Ther. 2012 Mar;19(3):264-70. doi: 10.1038/gt.2011.85. Epub 2011 Jun 30. Gene Ther. 2012. PMID: 21716303 Clinical Trial.

10

Therapeutic angiogenesis for peripheral artery disease: stem cell therapy.

Lachmann N, Nikol S. Lachmann N, et al. Among authors: nikol s. Vasa. 2007 Nov;36(4):241-51. doi: 10.1024/0301-1526.36.4.241. Vasa. 2007. PMID: 18357916 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page